Je veux savoir à propos de…

Federal Register / Vol. 86, No. 38 / Monday, March 1, 2021 / Notices alleges that an industry in the United States exists as required by section 337.
Id. The notice of investigation named numerous respondents, including Zhuhai Juxin Technology of Zhuhai, China. Id. at 85662. The Office of Unfair Import Investigations is not participating in the investigation. Id.
On February 4, 2021, US Synthetic filed an unopposed motion to substitute Guangdong Juxin New Materials Technology Co., Ltd. as a respondent in place of Zhuhai Juxin Technology.
On February 8, 2021, the ALJ issued Order No. 8, the subject ID, which granted the motion. The ID found that the motion complied with Commission Rule 210.14b1.
No party petitioned for review of the subject ID.
The Commission has determined not to review the ID. Accordingly, Guangdong Juxin New Materials Technology Co., Ltd.is substituted as a respondent in place of Zhuhai Juxin Technology.
The Commission vote for this determination took place on February 24, 2021.
The authority for the Commissions determination is contained in section 337 of the Tariff Act of 1930, as amended 19 U.S.C. 1337, and in Part 210 of the Commissions Rules of Practice and Procedure 19 CFR part 210.
By order of the Commission.
Issued: February 24, 2021.
Lisa Barton, Secretary to the Commission.
FR Doc. 202104164 Filed 22621; 8:45 am BILLING CODE 702002P

INTERNATIONAL TRADE
COMMISSION
Investigation No. 337TA1175

Certain Bone Cements and Bone Cement Accessories; Notice of Request for Statements on the Public Interest U.S. International Trade Commission.
ACTION: Notice.
AGENCY:

Notice is hereby given that on February 11, 2021, the presiding administrative law judge ALJ issued an Initial Determination on Violation of Section 337. The ALJ also issued a Recommended Determination on remedy and bonding should a violation be found in the above-captioned investigation. The Commission is soliciting submissions on public interest issues raised by the recommended relief
SUMMARY:

VerDate Sep<11>2014

18:48 Feb 26, 2021

Jkt 253001

should the Commission find a violation.
This notice is soliciting comments from the public only.
FOR FURTHER INFORMATION CONTACT:
Lynde Herzbach, Office of the General Counsel, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436, telephone 202
2053228. Copies of non-confidential documents filed in connection with this investigation may be viewed on the Commissions electronic docket EDIS
at https edis.usitc.gov. For help accessing EDIS, please email EDIS3Help@usitc.gov. General information concerning the Commission may also be obtained by accessing its internet server at https www.usitc.gov.
Hearing-impaired persons are advised that information on this matter can be obtained by contacting the Commissions TDD terminal, telephone 2022051810.
SUPPLEMENTARY INFORMATION: Parties are to file public interest submissions pursuant to 19 CFR 210.50a4.
Section 337 of the Tariff Act of 1930
provides that, if the Commission finds a violation, it shall exclude the articles concerned from the United States:
unless, after considering the effect of such exclusion upon the public health and welfare, competitive conditions in the United States economy, the production of like or directly competitive articles in the United States, and United States consumers, it finds that such articles should not be excluded from entry.

19 U.S.C. 1337d1. A similar provision applies to cease and desist orders. 19 U.S.C. 1337f1.
The Commission is soliciting submissions on public interest issues raised by the recommended relief should the Commission find a violation, specifically: A limited exclusion order directed to certain bone cements and bone cement accessories imported, sold for importation, and/or sold after importation by respondents Heraeus Medical GmbH of Wehrheim, Germany and Heraeus Medical LLC of Yardley, Pennsylvania collectively, Heraeus;
and cease and desist orders directed to Heraeus.
The Commission is interested in further development of the record on the public interest in this investigation.
Accordingly, members of the public are invited to file submissions of no more than five 5 pages, inclusive of attachments, concerning the public interest in light of the ALJs Recommended Determination on Remedy and Bonding issued in this investigation on February 11, 2021.
Comments should address whether issuance of the recommended remedial
PO 00000

Frm 00111

Fmt 4703

Sfmt 4703

12029

orders in this investigation, should the Commission find a violation, would affect the public health and welfare in the United States, competitive conditions in the United States economy, the production of like or directly competitive articles in the United States, or United States consumers.
In particular, the Commission is interested in comments that:
i Explain how the articles potentially subject to the recommended remedial orders are used in the United States;
ii identify any public health, safety, or welfare concerns in the United States relating to the recommended orders;
iii identify like or directly competitive articles that complainant, its licensees, or third parties make in the United States which could replace the subject articles if they were to be excluded;
iv indicate whether complainant, complainants licensees, and/or third-party suppliers have the capacity to replace the volume of articles potentially subject to the recommended orders within a commercially reasonable time; and v explain how the recommended orders would impact consumers in the United States.

Written submissions must be filed no later than by close of business on March 9, 2021.
Persons filing written submissions must file the original document electronically on or before the deadlines stated above. The Commissions paper filing requirements in 19 CFR 210.4f are currently waived. 85 FR 15798
March 19, 2020. Submissions should refer to the investigation number Inv.
No. 337TA1175 in a prominent place on the cover page and/or the first page. See Handbook for Electronic Filing Procedures, https
www.usitc.gov/documents/handbook_
on_filing_procedures.pdf. Persons with questions regarding filing should contact the Secretary 2022052000.
Any person desiring to submit a document to the Commission in confidence must request confidential treatment. All such requests should be directed to the Secretary to the Commission and must include a full statement of the reasons why the Commission should grant such treatment. See 19 CFR 201.6. Documents for which confidential treatment by the Commission is properly sought will be treated accordingly. All information, including confidential business information and documents for which confidential treatment is properly sought, submitted to the Commission for purposes of this Investigation may be disclosed to and used: i By the Commission, its employees and Offices, and contract personnel a for
E:FRFM01MRN1.SGM

01MRN1